Skip to content

Clinical trials

Terminated Sarcoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sarcoma Status: Terminated Country / region: United States Clear all

142 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20021
20031
20045
20055
20063
20075
20087
20096
20107
20115
20125
20132
20146
20155
20167
20176
20187
201910
20209
20219
20227
20234
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated142

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)15
Gynecologic Oncology Group6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
Washington University School of Medicine6
Mayo Clinic4
Memorial Sloan Kettering Cancer Center4
Pfizer4
City of Hope Medical Center3
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)3
M.D. Anderson Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sarcoma142
Melanoma26
Breast Neoplasms23
Neoplasms20
Colorectal Neoplasms18
Ovarian Neoplasms17
Lung Neoplasms16
Neoplasm Metastasis14
Pancreatic Neoplasms14
Carcinoma, Renal Cell13

Trials

Showing 1 to 25 of 142. Each trial links to its page on Pharma Observatory.

42 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.